Athanasios Tragiannidis Selected Research

Apolipoproteins E (ApoE)

3/2024

Effect of apolipoprotein E (APOE) gene polymorphisms on the lipid profile of children being treated for acute lymphoblastic leukemia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Athanasios Tragiannidis Research Topics

Disease

12	Neoplasms (Cancer) 11/2023 - 03/2012
12	Infections 01/2023 - 07/2009
7	Hematologic Neoplasms (Hematological Malignancy) 01/2024 - 07/2009
6	Mycoses (Diseases, Fungus) 11/2023 - 07/2009
5	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 03/2024 - 10/2022
5	COVID-19 01/2024 - 06/2022
5	Invasive Fungal Infections 10/2019 - 07/2009
4	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 04/2024 - 05/2011
4	Lymphoma (Lymphomas) 11/2023 - 03/2021
4	Leukemia 01/2023 - 03/2021
3	Sepsis (Septicemia) 01/2023 - 01/2019
3	Bacteremia 01/2023 - 01/2019
3	Hemorrhage 01/2021 - 05/2011
3	Candidemia 12/2020 - 09/2018
3	Communicable Diseases (Infectious Diseases) 09/2018 - 03/2012
2	Thrombocytopenia (Thrombopenia) 04/2024 - 01/2021
2	Cardiotoxicity 06/2023 - 01/2023
2	Invasive Pulmonary Aspergillosis 01/2023 - 12/2016
2	Aspergillosis 01/2023 - 01/2013
2	Febrile Neutropenia 01/2023 - 02/2017
2	Inflammation (Inflammations) 06/2022 - 04/2017
2	Graft vs Host Disease (Graft-Versus-Host Disease) 12/2020 - 04/2017
2	Biliary Atresia 01/2019 - 01/2018
2	Necrosis 08/2017 - 04/2017
2	Bone Marrow Failure Disorders 02/2017 - 07/2009
1	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 04/2024
1	Autoimmune Diseases (Autoimmune Disease) 04/2024
1	Osteosarcoma (Osteogenic Sarcoma) 11/2023
1	Hypersensitivity (Allergy) 06/2023
1	Virus Diseases (Viral Diseases) 01/2023
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2023
1	Agammaglobulinemia (Hypogammaglobulinemia) 10/2022
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 10/2022
1	Opportunistic Infections (Opportunistic Infection) 10/2022
1	Hemolysis 01/2022
1	Dysgammaglobulinemia 09/2021

Drug/Important Bio-Agent (IBA)

6	Antifungal AgentsIBA 09/2021 - 07/2009
5	Monoclonal AntibodiesIBA 01/2023 - 04/2017
4	Rituximab (Mabthera)FDA Link 10/2022 - 08/2017
3	Inosine Triphosphate (ITP)IBA 04/2024 - 05/2011
3	AntigensIBA 01/2023 - 03/2021
3	Chimeric Antigen ReceptorsIBA 01/2023 - 03/2021
3	pembrolizumabIBA 10/2022 - 03/2021
3	blinatumomabIBA 10/2022 - 03/2021
3	Inotuzumab OzogamicinIBA 10/2022 - 03/2021
3	liposomal amphotericin B FDA Link 12/2020 - 12/2016
2	Biomarkers (Surrogate Marker)IBA 02/2024 - 01/2023
2	MicroRNAs (MicroRNA)IBA 02/2024 - 11/2023
2	Folic Acid (Vitamin M)FDA LinkGeneric 11/2023 - 01/2020
2	Methotrexate (Mexate)FDA LinkGeneric 11/2023 - 01/2019
2	Voriconazole (Vfend)FDA LinkGeneric 11/2023 - 12/2016
2	Brentuximab VedotinIBA 10/2022 - 03/2021
2	nilotinib FDA Link 10/2022 - 09/2021
2	Imatinib Mesylate (Gleevec)FDA Link 10/2022 - 09/2021
2	Dasatinib (BMS 354825)FDA Link 10/2022 - 09/2021
2	Gemtuzumab (Mylotarg)FDA Link 10/2022 - 03/2021
2	tisagenlecleucelIBA 10/2022 - 03/2021
2	Immune Checkpoint InhibitorsIBA 01/2022 - 03/2021
2	Tyrosine Kinase InhibitorsIBA 01/2022 - 09/2021
2	NivolumabIBA 09/2021 - 03/2021
2	Alemtuzumab (Campath)FDA Link 03/2021 - 08/2017
2	Abatacept (Orencia)FDA Link 03/2021 - 08/2017
2	IpilimumabIBA 03/2021 - 08/2017
2	Basiliximab FDA Link 03/2021 - 08/2017
2	AntibodiesIBA 01/2021 - 09/2016
2	Amphotericin B (Amphotericin)FDA LinkGeneric 12/2020 - 02/2017
2	Anti-Bacterial Agents (Antibiotics)IBA 11/2020 - 01/2019
2	Hemoglobins (Hemoglobin)IBA 01/2019 - 01/2018
2	EchinocandinsIBA 09/2018 - 02/2017
2	Proteins (Proteins, Gene)FDA Link 08/2017 - 04/2017
2	CytokinesIBA 04/2017 - 08/2013
2	Intravenous Immunoglobulins (IVIG)FDA Link 01/2013 - 05/2011
1	Apolipoproteins E (ApoE)IBA 03/2024
1	ApolipoproteinsIBA 03/2024
1	LipidsIBA 03/2024
1	Asparaginase (Elspar)FDA Link 03/2024
1	Dexamethasone (Maxidex)FDA LinkGeneric 01/2024
1	molnupiravirIBA 10/2023
1	Antiviral Agents (Antivirals)IBA 10/2023
1	nirmatrelvir and ritonavir drug combinationIBA 10/2023
1	Cytarabine (Cytosar-U)FDA LinkGeneric 06/2023
1	galactomannanIBA 01/2023
1	LithostathineIBA 01/2023
1	proadrenomedullinIBA 01/2023
1	Bortezomib (Velcade)FDA Link 10/2022
1	venetoclaxIBA 10/2022
1	Complement System Proteins (Complement)IBA 06/2022
1	eculizumab FDA Link 01/2022
1	Alefacept (Amevive)FDA Link 03/2021
1	ibritumomab tiuxetan (Zevalin)FDA Link 03/2021
1	durvalumabIBA 03/2021
1	combotoxIBA 03/2021
1	avelumabIBA 03/2021

Therapy/Procedure

11	Drug Therapy (Chemotherapy) 01/2023 - 07/2009
7	Therapeutics 04/2024 - 08/2017
5	Hematopoietic Stem Cell Transplantation 01/2023 - 07/2009
4	Catheters 01/2023 - 05/2010
2	Cell Transplantation 01/2023 - 12/2020
1	Critical Care (Surgical Intensive Care) 01/2022
1	Artificial Respiration (Mechanical Ventilation) 03/2021